APA (7th ed.) Citation

Zschäbitz, S., & Grüllich, C. (2018). Lenvantinib: A tyrosine kinase inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET. Small molecules in oncology.

Chicago Style (17th ed.) Citation

Zschäbitz, Stefanie, and Carsten Grüllich. "Lenvantinib: A Tyrosine Kinase Inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET." Small Molecules in Oncology 2018.

MLA (9th ed.) Citation

Zschäbitz, Stefanie, and Carsten Grüllich. "Lenvantinib: A Tyrosine Kinase Inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET." Small Molecules in Oncology, 2018.